tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Burcon NutraScience to Discuss Q2 Financial Results Amid Growing Protein Sales

Story Highlights
  • Burcon NutraScience will hold a conference call on November 12, 2025, to discuss its Q2 financial results.
  • The company expects growing protein sales to drive revenue and margin expansion into 2026.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Burcon NutraScience to Discuss Q2 Financial Results Amid Growing Protein Sales

Meet Your ETF AI Analyst

Burcon Nutrascience ( (TSE:BU) ) has issued an announcement.

Burcon NutraScience announced it will hold a conference call on November 12, 2025, to discuss its fiscal 2026 second-quarter financial results. The company is experiencing increased momentum in protein sales as customers transition to commercial purchase orders, reaffirming its 2025 revenue target of $1-3 million. This growing demand is expected to drive revenue acceleration and margin expansion into 2026, highlighting Burcon’s strengthening position in the plant-based protein industry.

The most recent analyst rating on (TSE:BU) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on Burcon Nutrascience stock, see the TSE:BU Stock Forecast page.

Spark’s Take on TSE:BU Stock

According to Spark, TipRanks’ AI Analyst, TSE:BU is a Neutral.

Burcon Nutrascience’s overall stock score is primarily impacted by its poor financial performance, characterized by negative profitability and high leverage. While the earnings call provided some optimism with strategic agreements and production successes, the financial challenges and valuation concerns weigh heavily on the stock’s attractiveness.

To see Spark’s full report on TSE:BU stock, click here.

More about Burcon Nutrascience

Burcon NutraScience Corporation is a global technology leader specializing in high-performance plant-based proteins for the food and beverage industry. The company offers commercial ingredients that provide superior taste, texture, and functionality, ideal for formulators seeking next-generation protein solutions. With over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from various plant sources, such as pea, canola, soy, hemp, and sunflower. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and creating best-in-class protein solutions.

Average Trading Volume: 6,204

Technical Sentiment Signal: Sell

Current Market Cap: C$29.69M

For detailed information about BU stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1